Empresa Karolinska Development AB London S.E.
Acciones
0P3C
SE0002190926
Equipo médico, suministros y distribución
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,403 SEK | +48,79 % |
|
+55,67 % | +42,47 % |
28/05 | Karolinska Development apunta a una participación del 10% en Boost Pharma | MT |
16/05 | Karolinska Development AB (Publ) nombra a Hans Wigzell director y presidente | CI |
Resumen de negocios
Número de empleados: 8
Ventas por actividad
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43 % |
Ventas por región
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07/12/15 |
Director of Finance/CFO | 56 | 01/10/22 | |
John Öhd
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/06/20 |
Chief Investment Officer | 58 | 01/03/21 | |
Linda Spahiu
PRN | Corporate Officer/Principal | 39 | - |
Johan Dighed
LAW | General Counsel | 51 | 01/05/20 |
Corporate Officer/Principal | 59 | 01/11/15 | |
Eva Montgomerie
AUD | Comptroller/Controller/Auditor | 66 | 01/01/07 |
Thomas Andersson
PRN | Corporate Officer/Principal | 72 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07/12/15 |
Director/Board Member | 55 | 19/02/21 | |
Benjamin Toogood
BRD | Director/Board Member | 48 | 19/02/21 |
Theresa Tse
BRD | Director/Board Member | 32 | 28/11/17 |
Philip Duong
BRD | Director/Board Member | 34 | 12/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 10 | 2 555 261 | 0 | 0 | 35,19 % |
Acción B | 1 | 267 522 333 | 95 049 884 ( 35,53 %) | 244 285 ( 0,0913 %) |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
OSSDSIGN AB 9.83% | 9 596 662 | 9.83% | 8 427 501 $ |
Información de la empresa
Karolinska Development AB
Tomtebodavägen 23 A
171 65, Solna
+46 8 524 860 70
http://www.karolinskadevelopment.com![Dirección Karolinska Development AB(0P3C)](https://cdn.zonebourse.com/static/address/9276560.png)
Empresas del grupo
Nombre | Categoría y sector |
---|---|
KDev Investments AB
![]() KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. |
Biotechnology
|
Sector
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-6,68 % | 179 mil M | |
-5,20 % | 98,84 mil M | |
-5,38 % | 65,34 mil M | |
+15,46 % | 45,41 mil M | |
-6,47 % | 44,94 mil M | |
+9,74 % | 43,76 mil M | |
+14,01 % | 29,01 mil M | |
+19,39 % | 25,65 mil M | |
-6,53 % | 23,32 mil M |
- Bolsa de valores
- Acciones
- Acción KDEV
- Acción 0P3C
- Empresa Karolinska Development AB